malondialdehyde has been researched along with albuterol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aydin, S; Besirli, K; Cetinkaya, A; Ozaras, R; Tahan, V; Talay, F; Turkmen, S; Uzun, H | 1 |
| Gur'eva, SA; Lapik, SV; Medvedeva, IV; Savina, IA | 1 |
| Al Obaidi, AH; Al Samarai, AM | 1 |
| Chan, WP; Heresztyn, T; Horowitz, JD; Liberts, EA; Marber, MS; Norman, RJ; Rajendran, S; Saha, M; Willoughby, SR | 1 |
1 trial(s) available for malondialdehyde and albuterol
| Article | Year |
|---|---|
[Clinical and biochemical aspects of flixotide administration in patients with moderate bronchial asthma].
Topics: Adrenergic beta-Agonists; Adult; Albuterol; alpha-Tocopherol; Androstadienes; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Catalase; Drug Therapy, Combination; Female; Fluticasone; Glutathione Reductase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Phospholipids; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Schiff Bases; Superoxide Dismutase | 2002 |
3 other study(ies) available for malondialdehyde and albuterol
| Article | Year |
|---|---|
Changes in malondialdehyde levels in bronchoalveolar fluid and serum by the treatment of asthma with inhaled steroid and beta2-agonist.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Androstadienes; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Bronchodilator Agents; Female; Fluticasone; Forced Expiratory Volume; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Salmeterol Xinafoate | 2000 |
Biochemical markers as a response guide for steroid therapy in asthma.
Topics: Administration, Inhalation; Adolescent; Adult; Albuterol; Asthma; Beclomethasone; Biomarkers; Breath Tests; Cohort Studies; Confidence Intervals; Drug Resistance; Female; Follow-Up Studies; Glucocorticoids; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; Male; Malondialdehyde; Middle Aged; Monitoring, Physiologic; Predictive Value of Tests; Respiratory Function Tests; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome | 2008 |
Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects.
Topics: Adenosine Diphosphate; Adult; Albuterol; Arginine; Body Composition; C-Reactive Protein; Cohort Studies; Endothelial Cells; Endothelium, Vascular; Female; Humans; Inflammation Mediators; Malondialdehyde; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Nitroprusside; Obesity; Oxidative Stress; Platelet Aggregation; Platelet Function Tests; Polycystic Ovary Syndrome; Stem Cells; Time Factors; Vasodilator Agents | 2009 |